Recruiting studies: Covid 19 Vaccination

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100 Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829 Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NA · 1 location(s) · Johns Hopkins University · NCT06128928 Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome
Phase N/A · 1 location(s) · University of Bern · NCT07400848 COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06168032 SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06435403 Testimonials and Navigation in Rheumatology
NA · 3 location(s) · University of Alabama at Birmingham · NCT06469788 Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NA · 4 location(s) · RAND · NCT06156254 Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05078905 COMMUNITY - the COVID-19 Immunity Study
Phase N/A · 2 location(s) · Danderyd Hospital · NCT06784739 COVID-19 Transmission and Morbidity in Malawi
Phase N/A · 2 location(s) · Boston University · NCT05973084 Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption
NA · 1 location(s) · The Hong Kong Polytechnic University · NCT05539482 Evaluation of COVID-19 Immune Barrier and Reinfection Risk
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT05774093 COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
Phase N/A · 1 location(s) · Indiana University · NCT07128095 (COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT05384509 Neutralizing Power of Serum Antibodies - 2
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07085611 Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Phase N/A · 2 location(s) · Boston University · NCT06168019 Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
Phase N/A · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT04983251 Immunosuppression and COVID-19 Boosters
Phase 3 · 5 location(s) · Kirby Institute · NCT05415267 Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
NA · 1 location(s) · Iowa State University · NCT05213000 Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
Phase N/A · 1 location(s) · University of Bergen · NCT04706390 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Phase N/A · 1 location(s) · Consorci Sanitari de Terrassa · NCT04367883

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.